Skip to content

Discovery Highlights

In addition to exploring science by testing molecules in our disease-relevant assays, we also seek specific partnerships and collaborations.
We are now using PPI (protein-protein interaction) technology to produce the next class of small molecules that work like biologics but can be delivered orally for patients with inflammatory skin diseases who prefer to avoid injectable treatments. 
We are currently exploring partnerships related to PPI technologies using our two specific assays targeting the IL4-Receptor and STAT6.

We invite you test your molecules for the ability to inhibit the protein-protein interactions of those targets.

Protein-Protein Interaction

We are now using PPI (protein-protein interaction) technology to produce the next class of small molecules that work like biologics but can be delivered orally for patients with inflammatory skin diseases. Explore collaboration opportunities by testing your PPI modulators for IL4R or STAT6.

Here is how to test PPI molecules in Open Innovation.

Research Interests

In Research we cover all aspects of drug discovery and have additional interests and need for external collaborations. Here we have listed some that span across our traditional open innovation platform and include other research opportunities.

See our research interests here.

Scroll to top